OH
Optain Health
United States · Healthtech
Optain Health develops retinal imaging technology and AI software that help clinicians screen for eye disease and assess health risks.
Product
Its Eyetelligence Assure software and fundus camera capture and analyze retinal images, producing reports that support clinical decisions. Screening capabilities depend on the software option and jurisdiction.
Origins
The business grew from Australian company Eyetelligence and research led by ophthalmology specialist Professor Mingguang He. Jeff Dunkel serves as CEO.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Equity offering | $7.5M | Participants not disclosed |